You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫思健康(02138.HK)向年滿18歲入境旅客提供復必泰二價疫苗接種服務
阿思達克 01-10 17:12
醫思健康(02138.HK)公布,集團將透過旗下醫療中心向年滿18歲的赴港旅客提供復必泰二價疫苗服務。 集團表示,相關服務推出後獲得熱烈響應,目前已通過各商業夥伴及集團預約系統已收到數千份預約要求,並將透過旗下位於中環,旺角及銅鑼灣的共四間醫療中心專為跨境旅客提供疫苗注射服務,亦將以6人同行每針1,380元或單獨每針1,680元提供疫苗接種服務。 集團表示,面向本港居民疫苗接種需求,集團一直於港島及新界地區設有獨立服務診所點,同時對本港疫苗的充足供應感樂觀,期望能切實滿足本地客戶及跨境醫療旅客的需求,提升全民免疫水平,加快邁向疫後常態化復甦。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account